Big Pharma is able to charge Americans significantly higher prices and pad their profits.” Sen. Elizabeth Warren (D-Mass.) and Rep. Pramila Jayapal (D-Wash.) last month called again on Teva and ...

Amid a national spike in attention-deficit/hyperactivity disorder diagnoses, one of the U.S.’ top providers of a popular ADHD medication has run into supply ...

Eliciting an acceptable offer from Teva has been a particularly protracted battle for the states, tribes and municipalities that brought cases against it. While Purdue Pharma, for example ...

was about creating a sustainable generics powerhouse,” Francis said in an interview with Fierce Pharma on Wednesday. “In no way were we in a sense stepping away from generics.” Teva said the ...

It is changing from a generics market leader into one that is starting to compete directly with Big Pharma. Overall, Teva's price/sales ratio [FWD] is 1.53x. This is not only 58.4% lower relative ...

a subsidiary of NYSE-traded giant Teva Pharmaceuticals has signed a deal with medical cannabis company Canndoc to distribute its GMP products to pharma customers, including hospitals, health ...

SAN FRANCISCO (MarketWatch) -- Teva Pharmaceutical Industries Inc.'s current valuation doesn't reflect the expected rise in its per-share earnings over the next two years, according to a Citigroup ...

Shares of Teva Pharma marginally down 1% in early morning trading, while Alvotech's saw a 5% increase. Alvotech is in charge of development and manufacturing of Selarsdi, while Teva holds the ...

Teva’s betting big on biosimilars and specialty ... For a company that’s often painted as a problem child in pharma, that’s a pretty decent look. But it’s not all sunshine.

Dec 5 (Reuters) - Teva Pharmaceutical Industries (TEVA.TA), opens new tab said on Thursday it will transfer ownership of its business venture that sold generics in Japan to JKI. Israel-based Teva ...